11113-61-4

Basic information

• Product Name: DOWEX(R) 50WX4 HYDROGEN FORM
• Synonyms: ION EXCHANGER DOWEX 50 WX 4;DOWEX(R) 50 WX4;DOWEX(R) 50WX4-200;DOWEX(R) 50WX4-400;DOWEX(R) 50WX4 HYDROGEN FORM;DOWEX(R) 50X4-400;DOWEX 50 W X 4;DOWEX 50 W X 4-CATION EXCHANGER, STRONGLY ACIDIC
• CAS NO: 11113-61-4
• Molecular Formula: Na2O·Al2O3@2SiO2·4.50H2O
• Molecular Weight: 0
• Mol File: 11113-61-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /Beads
• Water Solubility: Insoluble in water.
• CAS DataBase Reference: DOWEX(R) 50WX4 HYDROGEN FORM(CAS DataBase Reference)
• NIST Chemistry Reference: DOWEX(R) 50WX4 HYDROGEN FORM(11113-61-4)
• EPA Substance Registry System: DOWEX(R) 50WX4 HYDROGEN FORM(11113-61-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 11113-61-4(Hazardous Substances Data)

Usage

Description

DOWEX(R) 50WX4 HYDROGEN FORM is a cation exchange resin in hydrogen form, characterized by its bead structure. It is designed for various applications in different industries, including pharmaceuticals and chemical processing, due to its unique properties and capabilities.

Uses

Used in Pharmaceutical Industry:
DOWEX(R) 50WX4 HYDROGEN FORM is used as a catalyst for the conversion of D,L-glyceraldehyde 3-phosphate diethyl acetal (barium salt) to free aldehyde D,L-glyceraldehyde 3-phosphate. This conversion is essential in the synthesis of certain pharmaceutical compounds.
Used in Chemical Processing Industry:
DOWEX(R) 50WX4 HYDROGEN FORM is used as a column packing material for anion exchange chromatography. Its unique bead structure and hydrogen form provide efficient separation and purification of various chemical compounds.
Used in Research and Development:
DOWEX(R) 50WX4 200-400 (H) is used to investigate the effect of particle size on drug loading and release profiles. This helps researchers understand the relationship between particle size and the performance of drug delivery systems, leading to the development of more effective pharmaceutical products.